ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 193 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,849,000 | -0.9% | 31,000 | +20.6% | 0.03% | +18.2% |
| Q1 2022 | $1,866,000 | +5.7% | 25,700 | +22.4% | 0.02% | +22.2% |
| Q4 2021 | $1,766,000 | -29.8% | 21,000 | -24.7% | 0.02% | -30.8% |
| Q3 2021 | $2,516,000 | +23.3% | 27,900 | +30.4% | 0.03% | +30.0% |
| Q2 2021 | $2,040,000 | -56.3% | 21,400 | -47.8% | 0.02% | -59.2% |
| Q1 2021 | $4,668,000 | -17.8% | 41,000 | 0.0% | 0.05% | -24.6% |
| Q4 2020 | $5,676,000 | +68.4% | 41,000 | 0.0% | 0.06% | +38.3% |
| Q3 2020 | $3,370,000 | +79.5% | 41,000 | +70.8% | 0.05% | +74.1% |
| Q2 2020 | $1,877,000 | +96.5% | 24,000 | +11.6% | 0.03% | +42.1% |
| Q1 2020 | $955,000 | -34.0% | 21,500 | -5.7% | 0.02% | -24.0% |
| Q2 2019 | $1,448,000 | -29.9% | 22,800 | -23.5% | 0.02% | -78.1% |
| Q1 2019 | $2,067,000 | +114.2% | 29,800 | +34.2% | 0.11% | +81.0% |
| Q4 2018 | $965,000 | -60.3% | 22,200 | -30.3% | 0.06% | -59.1% |
| Q3 2018 | $2,431,000 | -19.2% | 31,850 | -18.6% | 0.15% | -40.1% |
| Q2 2018 | $3,009,000 | +46.4% | 39,150 | -2.9% | 0.26% | +26.0% |
| Q1 2018 | $2,055,000 | +8.3% | 40,300 | -1.5% | 0.20% | +3.0% |
| Q4 2017 | $1,897,000 | -15.2% | 40,900 | -2.6% | 0.20% | -15.4% |
| Q3 2017 | $2,237,000 | +38.5% | 42,000 | 0.0% | 0.23% | +22.5% |
| Q2 2017 | $1,615,000 | -43.3% | 42,000 | 0.0% | 0.19% | -49.6% |
| Q1 2017 | $2,847,000 | -5.8% | 42,000 | -2.3% | 0.38% | -38.8% |
| Q4 2016 | $3,023,000 | -0.9% | 43,000 | 0.0% | 0.62% | +12.3% |
| Q3 2016 | $3,050,000 | +122.8% | 43,000 | +53.6% | 0.55% | +113.6% |
| Q2 2016 | $1,369,000 | +116.3% | 28,000 | +180.0% | 0.26% | +124.3% |
| Q1 2016 | $633,000 | – | 10,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
| RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
| First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
| CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
| Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
| Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
| SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |